Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Holman

Showing results (461-470 of 480) with videos related to

Pageof 48
Sort By:
Physiological Reports|August 26, 2021
Open or closed: Changes in ductus arteriosus flow patterns at birth using 4D flow MRI in newborn pigletsEric M Schrauben, Jack R T Darby, Mary J Berry, et al.
Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.
Frontiers in Physiology|January 30, 2025
Chronic fetal hypoxia and antenatal Vitamin C exposure differentially regulate molecular signalling in the lung of female lambs in early adulthoodErin V McGillick, Sandra Orgeig, Beth J Allison, et al.
Life Sciences|October 6, 2021
Intrauterine growth restriction alters the activity of drug metabolising enzymes in the maternal-placental-fetal unitGrace M McBride, Ashley S Meakin, Jia Yin Soo, et al.
Vaccine|November 2, 2010
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJ E Ledgerwood, P Costner, N Desai, et al.
Gynecologic Oncology|September 12, 2024
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14Jubilee Brown, Austin Miller, Laura L Holman, et al.
JCO Precision Oncology|July 9, 2025
Germline <i>POT1</i> Variants in a Pan-Cancer CohortPamela L Brock, Morgan Webster, Sandya Liyanarachchi, et al.
Gynecologic Oncology|March 9, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)Jeanne Carter, Helen Q Huang, Bradley J Monk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyShitanshu Uppal, Paola A Gehrig, Katherine Peng, et al.
Gynecologic Oncology|September 5, 2020
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?M H Vetter, S Smrz, P A Gehrig, et al.
Pageof 48

Showing results (461-470 of 480) with videos related to

Sort By:
Pageof 48
Physiological Reports|August 26, 2021
Open or closed: Changes in ductus arteriosus flow patterns at birth using 4D flow MRI in newborn pigletsEric M Schrauben, Jack R T Darby, Mary J Berry, et al.
Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.
Frontiers in Physiology|January 30, 2025
Chronic fetal hypoxia and antenatal Vitamin C exposure differentially regulate molecular signalling in the lung of female lambs in early adulthoodErin V McGillick, Sandra Orgeig, Beth J Allison, et al.
Life Sciences|October 6, 2021
Intrauterine growth restriction alters the activity of drug metabolising enzymes in the maternal-placental-fetal unitGrace M McBride, Ashley S Meakin, Jia Yin Soo, et al.
Vaccine|November 2, 2010
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJ E Ledgerwood, P Costner, N Desai, et al.
Gynecologic Oncology|September 12, 2024
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14Jubilee Brown, Austin Miller, Laura L Holman, et al.
JCO Precision Oncology|July 9, 2025
Germline <i>POT1</i> Variants in a Pan-Cancer CohortPamela L Brock, Morgan Webster, Sandya Liyanarachchi, et al.
Gynecologic Oncology|March 9, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)Jeanne Carter, Helen Q Huang, Bradley J Monk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyShitanshu Uppal, Paola A Gehrig, Katherine Peng, et al.
Gynecologic Oncology|September 5, 2020
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?M H Vetter, S Smrz, P A Gehrig, et al.
Pageof 48